Cogem

Search through the publications

Search publication ...

Search in: Full content Titles only

Quick search:

Contained Use Deliberate Release Market Authorisation

Advice following the European consultation on the authorisation process of GMOs in medical applications
COGEM advice Containment levels for laboratory activities involving lenti- and retroviral vectors
Inactivation of GM plant material

Highlighted publications

See more publications

17.11.2021

Risk Classification of Organisms: Pathogenicity classification of RNA and DNA viruses. Status November 2021

CGM/211117-01

Classification lists
04.10.2021

Risk Classification of Organisms: Pathogenicity classification of fungi. Status: October 2021

CGM/211004-01

Classification lists
20.08.2021

Advice following the European consultation on the authorisation process of GMOs in medical applications

CGM/210820-01

Advisory reports
24.03.2021

Generic environmental risk assessment of clinical trials with MVA vectors

CGM/210324-01

Advisory reports
22.03.2021

What is known about the import, distribution and presence of GM oilseed rape (Brassica napus) in the Netherlands?

CGM 2020-02

Research reports
01.07.2020

COGEM advice concerning the proposal by the EC to suspend the environmental risk assessment of clinical trials for the treatment or prevention of COVID-19

CGM/200624-01

Advisory reports

Ongoing projects

18.01.2022

Advice on the second renewal of the authorisation for import and processing of genetically modified oilseed rape MS8, RF3 and MS8xRF3

expected | 31.01.2022